|Robert Uhl||Westwicke Partners|
|Richard Fair||President, CEO & Director|
|Wangzhi Li||Ladenburg Thalmann & Co.|
Greetings, and welcome to the Bellicum Pharmaceuticals Fourth Quarter 2020 Financial Results and Corporate Update Conference Call. [Operator Instructions]. I will now turn the conference over to our host, Robert Uhl of Westwicke ICR. Thank you.
You may begin.